184 related articles for article (PubMed ID: 16943655)
1. Serum biomarkers after traumatic and hypoxemic brain injuries: insight into the biochemical response of the pediatric brain to inflicted brain injury.
Berger RP; Adelson PD; Richichi R; Kochanek PM
Dev Neurosci; 2006; 28(4-5):327-35. PubMed ID: 16943655
[TBL] [Abstract][Full Text] [Related]
2. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
Berger RP; Adelson PD; Pierce MC; Dulani T; Cassidy LD; Kochanek PM
J Neurosurg; 2005 Jul; 103(1 Suppl):61-8. PubMed ID: 16122007
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children.
Beers SR; Berger RP; Adelson PD
J Neurotrauma; 2007 Jan; 24(1):97-105. PubMed ID: 17263673
[TBL] [Abstract][Full Text] [Related]
4. Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool.
Berger RP; Dulani T; Adelson PD; Leventhal JM; Richichi R; Kochanek PM
Pediatrics; 2006 Feb; 117(2):325-32. PubMed ID: 16452350
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.
Geyer C; Ulrich A; Gräfe G; Stach B; Till H
J Neurosurg Pediatr; 2009 Oct; 4(4):339-44. PubMed ID: 19795965
[TBL] [Abstract][Full Text] [Related]
6. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM
Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241
[TBL] [Abstract][Full Text] [Related]
7. Serum biomarker concentrations and outcome after pediatric traumatic brain injury.
Berger RP; Beers SR; Richichi R; Wiesman D; Adelson PD
J Neurotrauma; 2007 Dec; 24(12):1793-801. PubMed ID: 18159990
[TBL] [Abstract][Full Text] [Related]
8. The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury.
Topolovec-Vranic J; Pollmann-Mudryj MA; Ouchterlony D; Klein D; Spence J; Romaschin A; Rhind S; Tien HC; Baker AJ
J Trauma; 2011 Nov; 71(5 Suppl 1):S478-86. PubMed ID: 22072007
[TBL] [Abstract][Full Text] [Related]
9. S100B is not a reliable prognostic index in paediatric TBI.
Piazza O; Storti MP; Cotena S; Stoppa F; Perrotta D; Esposito G; Pirozzi N; Tufano R
Pediatr Neurosurg; 2007; 43(4):258-64. PubMed ID: 17627141
[TBL] [Abstract][Full Text] [Related]
10. Urinary S100B concentrations are increased after brain injury in children: A preliminary study.
Berger RP; Kochanek PM
Pediatr Crit Care Med; 2006 Nov; 7(6):557-61. PubMed ID: 17006387
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury.
Nylén K; Ost M; Csajbok LZ; Nilsson I; Hall C; Blennow K; Nellgård B; Rosengren L
Acta Neurochir (Wien); 2008 Mar; 150(3):221-7; discussion 227. PubMed ID: 18193148
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.
Shore PM; Berger RP; Varma S; Janesko KL; Wisniewski SR; Clark RS; Adelson PD; Thomas NJ; Lai YC; Bayir H; Kochanek PM
J Neurotrauma; 2007 Jan; 24(1):75-86. PubMed ID: 17263671
[TBL] [Abstract][Full Text] [Related]
13. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.
Honda M; Tsuruta R; Kaneko T; Kasaoka S; Yagi T; Todani M; Fujita M; Izumi T; Maekawa T
J Trauma; 2010 Jul; 69(1):104-9. PubMed ID: 20093985
[TBL] [Abstract][Full Text] [Related]
14. [Serum S-100B protein and neuron-specific enolase after traumatic brain injury].
Sawauchi S; Taya K; Murakami S; Ishi T; Ohtsuka T; Kato N; Kaku S; Tanaka T; Morooka S; Yuhki K; Urashima M; Abe T
No Shinkei Geka; 2005 Nov; 33(11):1073-80. PubMed ID: 16277220
[TBL] [Abstract][Full Text] [Related]
15. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy.
Celtik C; Acunaş B; Oner N; Pala O
Brain Dev; 2004 Sep; 26(6):398-402. PubMed ID: 15275704
[TBL] [Abstract][Full Text] [Related]
16. Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury.
Berger RP; Bazaco MC; Wagner AK; Kochanek PM; Fabio A
Dev Neurosci; 2010; 32(5-6):396-405. PubMed ID: 20847541
[TBL] [Abstract][Full Text] [Related]
17. [Clinical values of detection of serum levels of S100B and NSE in diagnosis of brain injuries at early period after cardiopulmonary bypass].
Gu XH; Zhang G; Zhang XQ; Song Y; Wang T; Li SX
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):975-7. PubMed ID: 17650423
[TBL] [Abstract][Full Text] [Related]
18. [The role of S100B-protein in neonatology, pediatric intensive care, and pediatrics].
Meyer S; Gottschling S; Baghai A; Polcher T; Strittmatter M; Gortner L
Klin Padiatr; 2006; 218(2):49-56. PubMed ID: 16506102
[TBL] [Abstract][Full Text] [Related]
19. Multiplex assessment of serum biomarker concentrations in well-appearing children with inflicted traumatic brain injury.
Berger RP; Ta'asan S; Rand A; Lokshin A; Kochanek P
Pediatr Res; 2009 Jan; 65(1):97-102. PubMed ID: 18787505
[TBL] [Abstract][Full Text] [Related]
20. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.
Baker AJ; Rhind SG; Morrison LJ; Black S; Crnko NT; Shek PN; Rizoli SB
J Neurotrauma; 2009 Aug; 26(8):1227-40. PubMed ID: 19637968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
